Skip to main content

and
  1. No Access

    Article

    A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types

    Tumor neoepitopes presented by major histocompatibility complex (MHC) class I are recognized by tumor-infiltrating lymphocytes (TIL) and are targeted by adoptive T-cell therapies. Identifying which mutant neoe...

    Jared J. Gartner, Maria R. Parkhurst, Alena Gros, Eric Tran in Nature Cancer (2021)

  2. No Access

    Protocol

    Genetic and Functional Analysis of GRIN2A in Tumor Samples

    Ionotropic glutamate receptors (iGluRs) are large integral membrane multi-protein complexes that create ion channels in plasma membranes. Upon binding of receptor specific ligands (e.g., glutamate), increased ...

    Todd D. Prickett, Jared J. Gartner, Yardena Samuels in NMDA Receptors (2017)

  3. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

    Andreas Lundqvist, Vincent van Hoef, **aonan Zhang in Journal for ImmunoTherapy of Cancer (2016)

  4. No Access

    Article

    Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

    Steven Rosenberg and colleagues report that PD-1 is a biomarker of CD8+ T cells in the blood that recognize mutated neoantigens in melanoma.

    Alena Gros, Maria R Parkhurst, Eric Tran, Anna Pasetto, Paul F Robbins in Nature Medicine (2016)

  5. Article

    Open Access

    Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma

    Jessica S Crystal, Todd D Prickett, Jared J Gartner in Journal for ImmunoTherapy of Cancer (2015)

  6. Article

    Open Access

    Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

    Alena Gros, Eric Tran, Maria R Parkhurst in Journal for ImmunoTherapy of Cancer (2015)

  7. Article

    Open Access

    Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer

    Yasmine Assadipour, Stephanie Goff in Journal for ImmunoTherapy of Cancer (2015)

  8. Article

    Open Access

    Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens

    Todd D Prickett, Jessica S Crystal, Jared J Gartner in Journal for ImmunoTherapy of Cancer (2015)

  9. Article

    Open Access

    Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer

    Drew C Deniger, Mini Bharathan, Pasetto Anna in Journal for ImmunoTherapy of Cancer (2015)

  10. Article

    Open Access

    Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens

    Ken-ichi Hanada, Christopher Chow, Raul Gil Hoyos in Journal for ImmunoTherapy of Cancer (2015)

  11. Article

    Open Access

    Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

    Kasia Trebska-Mcgowan, Mini Bharathan in Journal for ImmunoTherapy of Cancer (2015)

  12. Article

    Open Access

    High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity

    Pasetto Anna, Alena Gros, Paul F Robbins in Journal for ImmunoTherapy of Cancer (2015)

  13. Article

    Open Access

    Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients

    Cyrille Cohen, Jared J Gartner in Journal for ImmunoTherapy of Cancer (2015)

  14. No Access

    Article

    Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma

    Yardena Samuels and colleagues sequenced G protein-coupled receptors in 11 melanoma samples and report a comprehensive map of somatic variants in the GPCR gene family. They find frequent mutations in GRM3, whi...

    Todd D Prickett, **aomu Wei, Isabel Cardenas-Navia, Jamie K Teer in Nature Genetics (2011)

  15. No Access

    Article

    Exome sequencing identifies GRIN2A as frequently mutated in melanoma

    Yardena Samuels and colleagues report the sequencing of 14 melanoma exomes. They identify a recurrent mutation in TRRAP in 4% of cases as well as mutations in GRIN2A in 33% of tumors.

    **aomu Wei, Vijay Walia, Jimmy C Lin, Jamie K Teer, Todd D Prickett in Nature Genetics (2011)

  16. No Access

    Article

    Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4

    Yardena Samuels and colleagues report a mutational analysis of the protein tyrosine kinase family in cutaneous metastatic melanoma. They find ERBB4 mutations in 19% of tumors and show that these mutations enhance...

    Todd D Prickett, Neena S Agrawal, **aomu Wei, Kristin E Yates in Nature Genetics (2009)

  17. No Access

    Article

    Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma

    Yardena Samuels and colleagues report a mutational analysis of the matrix metalloproteinase gene family in cutaneous metastatic melanoma. They find frequent somatic mutations in MMP8 and present functional eviden...

    Lavanya H Palavalli, Todd D Prickett, John R Wunderlich, **aomu Wei in Nature Genetics (2009)